Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on March 23, 2016. The report discloses the entry into a material definitive agreement dated November 6, 2015. Note: The request metadata references "Sonoma Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Oculus Innovative Sciences, Inc.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a contractual agreement rather than financial performance data.
Material Changes and Agreements
The company entered into an exclusive sales and distribution agreement with Manna Pro Products, LLC. Key terms include:
- Scope: Manna Pro serves as the exclusive sales representative and distributor for non-prescription animal care products to farm animal specialty stores and veterinarians in the U.S. and Canada.
- Non-Exclusive Role: Manna Pro acts as a non-exclusive distributor for grocery stores and mass retailers in the U.S. and Canada.
- Compensation: Manna Pro receives a commission based on a percentage of sales exceeding a specific bonus trigger.
- Term: The agreement has an initial term of five years with automatic year-to-year renewal unless terminated with 60 days' notice.
- Obligations: Manna Pro agreed to minimum purchase and marketing expenditure requirements.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the company's intentions and expectations. Management notes that actual results may differ materially due to risks and uncertainties discussed in the company's Annual Report on Form 10-K. No specific financial guidance or outlook was provided in this document.
Investor Verification Checklist
- Verify the exact commission structure and the "bonus trigger" threshold, as confidential treatment was sought for portions of the agreement.
- Confirm the specific minimum purchase and marketing expenditure requirements agreed upon by Manna Pro.
- Review the full text of Exhibit 10.1 (Exclusive Sales and Distribution Agreement) for termination clauses and performance metrics.
- Check subsequent filings to assess the commercial impact of this distribution channel on future revenue.